miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma

Haematologica. 2021 Feb 1;106(2):610-613. doi: 10.3324/haematol.2019.241307.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Cell Line, Tumor
  • Child
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymphoma, Large-Cell, Anaplastic* / genetics
  • MicroRNAs* / genetics
  • Receptor Protein-Tyrosine Kinases / genetics
  • Transcription Factors / genetics

Substances

  • JunB protein, human
  • MIRN939 microRNA, human
  • MicroRNAs
  • Transcription Factors
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases

Grant support

Funding: this work was supported by Fondazione Città della Speranza, Padova, Italy; Fondazione CA.RI.PA.RO, Padova, Italy (grant 17/03 to LM); Camera di Commercio Venezia, Venezia, Italy; Fondazione Roche, Roma, Italy (grant to FL) and Fondazione Umberto Veronesi, Milano, Italy (fellowship to FL); Associazione Italiana contro le Leucemie, sezione provinciale di Treviso (grant to BA).